Market Pulse

Event summary

• NetraMark’s contract backlog increased to C$2.5 million, moving the company closer to its mid-2026 target of C$8–10 million.
• The company completed onboarding with Worldwide Clinical Trials, enabling inclusion in Phase 2 and 3 bids for CNS and Oncology trials.
• NetraMark held a Critical Path Innovation Meeting (CPIM) with the FDA to discuss its NetraAI platform’s application in clinical trial design.
• A peer-reviewed study highlighting NetraAI’s capabilities was accepted for publication in npj Digital Medicine, part of the Nature Portfolio.
• NetraMark secured an Ontario Research Fund – Research Excellence (ORF-RE) Award in collaboration with the Centre for Addiction and Mental Health (CAMH).

The big picture

What we're watching

Execution Risk

The company's ability to convert its growing backlog into revenue will be crucial, as revenue recognition is tied to project-specific timelines and data readouts.

Regulatory Headwinds

While the FDA CPIM was constructive, NetraMark’s pursuit of the MIDD Paired Meeting Program hinges on a pharmaceutical sponsor's willingness to collaborate, introducing a dependency.

Channel Dependency

NetraMark’s reliance on Worldwide Clinical Trials for market access creates a potential bottleneck; the success of this partnership will significantly impact the company’s growth trajectory.

Event summary

• Tidal Cyber received 'Threat-Led Defense Company of the Year' recognition from GRC Outlook on December 18, 2025.
• The award highlights Tidal Cyber's focus on 'Threat-Led Defense,' a strategy centered on real adversary behavior.
• The company was founded in 2021 by former MITRE leaders Rick Gordon, Frank Duff, and Richard Struse.
• Tidal Cyber’s platform utilizes NARC™ AI to transform threat intelligence into ATT&CK-aligned Procedures, creating Coverage Maps.

The big picture

What we're watching

Governance Dynamics

The increasing integration of GRC with proactive threat defense suggests a broader shift in corporate risk management, potentially increasing demand for specialized platforms like Tidal Cyber's.

Competitive Landscape

Given the founders' backgrounds at MITRE, Tidal Cyber's success will depend on its ability to differentiate its commercial offering from MITRE's open-source ATT&CK framework and avoid direct competition.

Adoption Rate

The effectiveness of Tidal Cyber’s approach hinges on the willingness of organizations to move beyond traditional vulnerability-centric security models and adopt a behavior-driven defense strategy, which may require significant cultural and operational changes.

Event summary

• Latin Metals Inc. is spinning out its Para Copper and Auquis Copper projects into a new subsidiary, Latin Explore Inc.
• A Supreme Court of British Columbia interim order has been obtained to facilitate the spin-out via a plan of arrangement.
• A non-brokered private placement (Concurrent Financing) has been upsized to CAD $3 million, with subscription receipts priced at CAD $0.10 each.
• Shareholders will vote on the arrangement, share exchange, and incentive plan on January 14, 2026.
• Following the arrangement, Finco shareholders are expected to hold approximately 69% of Latin Explore shares.

The big picture

What we're watching

Shareholder Approval

The success of the arrangement hinges on shareholder approval, and a failure to secure the required votes could derail the spin-out and impact Latin Metals' strategic direction.

Finco Alignment

The significant ownership stake held by Finco shareholders in Latin Explore will likely influence the new entity’s operational and strategic decisions, requiring careful management of potential conflicts of interest.

TSXV Listing

Latin Explore’s ability to secure and maintain a listing on the TSXV will depend on meeting the exchange’s requirements, including demonstrating sufficient exploration activity and financial stability.

Event summary

• Lamborghini is implementing PTC's Windchill (PLM), Codebeamer (ALM), and Creo (CAD) software suite to streamline product development.
• The collaboration aims to improve data traceability, engineering change management, and cross-departmental collaboration at Lamborghini.
• Lamborghini is showcasing the integrated solution at CES 2026, demonstrating a front bumper lifecycle example using AI-powered tools.
• Lamborghini is the first super sports car brand to offer a fully hybridized lineup, including the Revuelto, Urus SE, and Temerario.

The big picture

What we're watching

Integration Risk

The success of PTC's implementation hinges on Lamborghini's ability to adapt its workflows and fully adopt the new software, which could face internal resistance or require significant training.

AI Adoption

The demonstrated AI capabilities (Codebeamer AI, Windchill AI, ServiceMax AI) will need to prove tangible ROI beyond initial demonstrations to justify the investment and drive broader adoption within Lamborghini.

Competitive Response

Other luxury automotive brands will likely observe Lamborghini's experience with PTC's suite, potentially accelerating their own PLM/ALM modernization efforts and intensifying competition for PTC's services.

Event summary

• Novo Nordisk submitted a New Drug Application (NDA) to the FDA for CagriSema, a once-weekly combination of cagrilintide and semaglutide, on December 18, 2025.
• REDEFINE 1 trial data showed an average weight loss of 20.4% with CagriSema versus 3.0% with placebo, when evaluating the treatment effect regardless of patient adherence.
• CagriSema combines a novel amylin analogue (cagrilintide) with semaglutide, targeting complementary obesity pathways.
• The FDA is expected to review the application in 2026.

The big picture

What we're watching

Regulatory Risk

The FDA review process could be impacted by increasing scrutiny of obesity drugs and their potential side effects, potentially delaying or impacting approval.

Market Adoption

The success of CagriSema will depend on physician and patient acceptance, which could be influenced by the drug's cost and potential gastrointestinal side effects.

Pipeline Competition

Novo Nordisk's market share in obesity treatment could be challenged by competing therapies in development, requiring continued innovation and differentiation.

Event summary

• Revolution Medicines initiated enrollment in Phase 3 trial RASolute 304, evaluating daraxonrasib in patients with resectable pancreatic ductal adenocarcinoma (PDAC) following adjuvant chemotherapy.
• The trial aims to enroll approximately 500 patients with PDAC harboring oncogenic RAS mutations.
• Daraxonrasib is a RAS(ON) multi-selective inhibitor, targeting mutations including G12X, G13X, and Q61X.
• This is one of four Phase 3 trials currently evaluating daraxonrasib, with three focused on PDAC and one on non-small cell lung cancer.

The big picture

What we're watching

Clinical Efficacy

The trial's primary endpoint, disease-free survival, will be a key indicator of daraxonrasib's potential to meaningfully impact PDAC outcomes, given the disease's poor prognosis.

Regulatory Pathway

Success in RASolute 304 will be crucial for Revolution Medicines to secure regulatory approval for daraxonrasib, potentially opening up a significant market opportunity in a disease with high unmet need.

Competitive Landscape

The trial's results will be compared against standard observation, and the emergence of competing RAS inhibitors could impact daraxonrasib's market share and pricing strategy.

Event summary

• Fusemachines (NASDAQ:FUSE) publicly outlined a growth strategy focused on 2026.
• The strategy centers on four pillars: vertical product innovation, organic growth, strategic partnerships, and selective acquisitions.
• The company is prioritizing retail and real estate as its primary vertical focus areas.
• Fusemachines recently held an AMA session with GateWatchHQ to discuss the strategy and address investor questions.
• The company is expanding responsible AI governance features and AI education programs.

The big picture

What we're watching

Execution Risk

The success of Fusemachines’ strategy hinges on its ability to effectively execute across four distinct pillars, which could strain resources and management focus.

Vertical Traction

While retail and real estate are prioritized, the company must demonstrate sustained demand and ROI within these verticals to justify its focus and avoid spreading resources too thin.

Partnership Dynamics

The reliance on global resellers and systems integrators introduces a layer of complexity; Fusemachines’ growth will depend on the ability to cultivate and manage these partnerships effectively.

Event summary

• BigCommerce, a subsidiary of Commerce.com (CMRC), has integrated with Stripe’s new Agentic Commerce Suite.
• The integration allows BigCommerce merchants to utilize AI agents for product discovery and checkout.
• Stripe’s Agentic Commerce Suite aims to simplify AI integration, previously requiring months of bespoke engineering.
• The suite supports agentic discovery, flexible checkout, merchant-of-record status, and fraud protection via Shared Payment Tokens (SPTs) and Stripe Radar.

The big picture

What we're watching

Adoption Rate

The pace at which BigCommerce merchants adopt the Agentic Commerce Suite will indicate the true demand for AI-driven sales and Stripe’s ability to deliver on its promise of simplified integration.

Competitive Response

Other ecommerce platform providers will likely accelerate their own AI agent integrations, potentially creating a competitive landscape for both BigCommerce and Stripe.

Fraud Risk

The effectiveness of Stripe’s fraud protection measures (SPTs and Radar) in mitigating risks associated with non-human traffic will be crucial for maintaining merchant trust and avoiding financial losses.

Event summary

• Genius Group Limited (GNS) has engaged DLA Piper as advisor for a dual listing on the Australian Securities Exchange (ASX).
• The decision follows a review of potential Asia-Pacific exchanges, including the Hong Kong Exchange (HKEX) and the Korea Exchange (KRX).
• DLA Piper will prepare and lodge an 'In Principle Advice Application' with ASX within 45 days.
• The dual listing process is expected to take approximately four months and is subject to ASX approval.
• Genius Group is utilizing CHESS Depositary Interests (CDIs) to facilitate trading on the ASX for US-based investors.

The big picture

What we're watching

Regulatory Approval

The success of the dual listing hinges on ASX approval, which could be impacted by evolving regulatory frameworks for US-listed companies seeking secondary listings in Asia-Pacific markets.

CDI Adoption

The uptake of CHESS Depositary Interests (CDIs) by Asia-Pacific investors will be a key indicator of the listing’s success and the potential for increased liquidity.

Market Sentiment

Genius Group’s stock performance will be influenced by broader investor sentiment towards AI-powered education and Bitcoin-first business models in the Asia-Pacific region.

Event summary

• IDrive Inc. launched 'IDrive Salesforce Backup' on December 18, 2025.
• The service provides automated cloud-to-cloud backup and granular recovery for Salesforce data and metadata.
• Pricing is $20/user/seat/year with unlimited storage, or $2/seat/month.
• The service supports SOC 2 Type 2, SEC, SOX, and HIPAA compliance standards.

The big picture

What we're watching

Adoption Rate

The success of IDrive Salesforce Backup hinges on convincing Salesforce users, many of whom may be unaware of the data protection gap, to adopt a third-party backup solution.

Competitive Landscape

Existing Salesforce ecosystem partners and emerging data protection specialists will likely respond, potentially creating pricing pressure and requiring IDrive to differentiate its offering beyond basic functionality.

Salesforce Integration

IDrive's ability to maintain seamless integration with evolving Salesforce platforms and APIs will be critical for long-term customer retention and expansion of the service.

Event summary

• Avetta’s Vetify service has helped Hatzel & Buehler, a commercial electrical contractor, reduce administrative time spent on compliance renewals by 50%.
• Hatzel & Buehler, with 2,000 employees and 20+ branches, manages compliance for over 60 clients across multiple states.
• Vetify accelerates new client onboarding for Hatzel & Buehler, shortening the process from weeks to days.
• The solution manages COI management, documentation processing, and issue resolution, freeing up Hatzel & Buehler staff for other strategic initiatives.

The big picture

What we're watching

Adoption Rate

The success of Avetta’s Vetify hinges on broader adoption among contractors facing increasingly complex compliance requirements; limited uptake could cap revenue growth.

Competitive Landscape

The SCRM space is becoming increasingly crowded, and Avetta must demonstrate Vetify’s differentiated value proposition to maintain its market position and fend off competitors.

Client Retention

Hatzel & Buehler’s positive experience is a strong signal, but Avetta’s ability to replicate these results across a wider client base will be crucial for long-term success and retention.

Event summary

• Aptiv PLC and Vecna Robotics have entered a strategic collaboration to co-develop next-generation Autonomous Mobile Robot (AMR) solutions.
• The partnership integrates Aptiv’s perception hardware (PULSE™ sensor) and machine learning technologies with Vecna Robotics’ autonomy and orchestration platform (CaseFlow™).
• Aptiv will showcase Vecna Robotics’ CPJ Co-Bot Pallet Jack at CES 2026.
• The collaboration aims to deliver cost-efficient automation at scale across industrial environments.

The big picture

What we're watching

Competitive Landscape

The success of this partnership will depend on Aptiv and Vecna’s ability to differentiate their combined offering from established AMR providers and navigate increasing competition in the industrial automation space.

Integration Risk

Integrating Aptiv’s software and compute platform with Vecna’s autonomy platform presents integration risks that could delay product launches or impact performance if not managed effectively.

Adoption Rate

The pace at which industrial customers adopt these new AMR solutions will be influenced by factors such as capital expenditure budgets and the availability of skilled labor to manage and maintain the systems.

Event summary

• EY has launched the EY Government and Public Sector (GPS) Chief Information Officer (CIO) Advisor in Residence Program, effective December 18, 2025.
• The program is an initiative of the EY Center for Government Modernization, designed to support state-level technology leaders.
• The program leverages a CIO Advisory Council composed of former state CIOs, including Claire Bailey, James Collins, Chris Estes, Lori Victor Feller, Doug Holt, Karen Robinson, and Michael Tosh.
• The program aims to address challenges like evolving cyber threats, budget pressures, and the complexities of governor appointments.

The big picture

What we're watching

Governance Dynamics

The program’s success hinges on the active participation and influence of the Advisory Council; a lack of engagement could undermine its intended impact on state CIO decision-making.

Talent Retention

Whether the program can effectively address the broader issue of talent retention within state government IT departments remains to be seen, as mentorship alone may not solve systemic workforce challenges.

EY’s Expansion

The program’s rollout and expansion to other levels of government (federal, local) will indicate the broader market demand for EY’s public sector advisory services and its strategic priorities.

Event summary

• Sezzle’s MoneyIQ program has reached 1 million lessons completed in its first year.
• Over 200,000 users have engaged with the financial literacy program embedded within the Sezzle app.
• A November 2024 survey indicated only 37% of Sezzle respondents felt confident about their finances.
• A follow-up survey after MoneyIQ’s rollout showed 51% of users now feel “very confident” about their finances.

The big picture

What we're watching

User Retention

Whether the initial surge in user confidence and engagement with MoneyIQ translates into sustained BNPL usage and reduced delinquency rates remains to be seen.

Competitive Response

Other BNPL providers will likely observe Sezzle’s success and may attempt to replicate similar financial literacy initiatives, potentially commoditizing the offering.

Regulatory Scrutiny

The integration of financial education into a BNPL platform could draw increased regulatory attention regarding the potential for misleading or manipulative practices.

Event summary

• PublicSquare (PSQH) entered into a definitive agreement with an existing institutional investor for a registered direct offering.
• The offering involves 6,818,184 shares of Class A common stock (or pre-funded warrants) and warrants to purchase up to 8,522,730 shares.
• The combined purchase price per share and warrant is $1.10, with warrants exercisable six months after issuance.
• The offering is expected to close on December 19, 2025, and will generate approximately $7.5 million in gross proceeds.
• Net proceeds will be used for general corporate purposes, including working capital.

The big picture

What we're watching

Capital Allocation

The company's stated use of proceeds for 'general corporate purposes' lacks specificity, and future disclosures will be critical to assess whether the capital is deployed effectively to drive growth or address operational challenges.

Investor Base

The fact that an *existing* institutional investor is participating suggests some level of confidence, but the size of the offering and the warrant structure may signal concerns about broader market appetite for the stock.

Values Alignment

PublicSquare's stated commitment to 'values-driven innovation' is a core part of its brand, and future product development and marketing initiatives will need to consistently reinforce this positioning to maintain investor and customer loyalty.

Event summary

• McFarlane Lake Mining has begun a 13,000-meter exploration drilling program at its 100%-owned Juby Gold Project in Ontario.
• The program targets expansion of known mineralization and depth/strike potential across four zones: Juby, Golden Lake, Big Dome, and Hydro Creek.
• The initial drilling phase will focus on the 826 zone, following up on 2013 exploration results.
• McFarlane’s Juby Gold Project currently holds a NI 43-101 compliant Mineral Resource Estimate of 4.21 million ounces of gold.
• The drilling campaign is expected to be completed by May 2026.

The big picture

What we're watching

Resource Validation

The success of this drilling program hinges on its ability to expand the current resource estimate and convert inferred resources to indicated categories, which will significantly impact valuation.

Geological Risk

The 826 zone follow-up drilling carries geological risk; the initial 2013 results may not be representative of the zone's overall mineralization potential.

Cost Management

Given the $13 million budget and projected May 2026 completion date, the company’s ability to manage costs and maintain operational efficiency will be critical to shareholder returns.

Event summary

• Domestic Metals Corp. granted stock options totaling 2.7 million shares to directors, officers, and consultants with an exercise price of $0.25 per share, expiring December 27, 2030.
• The company is preparing for a diamond drill program in Q1 2026 at the Smart Creek Copper Porphyry Project in Montana, a joint venture with Rio Tinto.
• Rio Tinto has previously drilled 26 of 40 permitted sites at Smart Creek, reporting a significant intercept of 109.73 meters @ 0.75% Cu.
• Fieldwork at the Sunrise Mine Target has identified a quartz vein stockwork with 4.26 g/t gold, advancing the target to the drill testing phase.

The big picture

What we're watching

Drill Results

The success of the Q1 2026 drill program at Smart Creek will be critical in validating the company’s geological interpretation and potentially unlocking significant copper and gold resources.

Rio Tinto Commitment

Rio Tinto’s continued investment and participation in the Smart Creek joint venture will be a key indicator of the project’s perceived potential.

Shareholder Sentiment

The stock option grants, while standard practice, may influence shareholder perception of management alignment and the company’s long-term prospects given the current share price.

Event summary

• Nouveau Monde Graphite (NMG) priced an 8,333,334 share public equity offering at $2.40 per share, gross proceeds of $20 million.
• The offering is solely for US investors and will close on or about December 19, 2025, subject to customary approvals.
• Proceeds will fund long-lead equipment procurement, construction activities, engineering for the Matawinie Mine and Bécancour Battery Material Plant projects, and general working capital.
• Maxim Group LLC is acting as the sole placement agent for the offering.

The big picture

What we're watching

Project Execution

The successful deployment of the raised capital into the Matawinie Mine and Bécancour Battery Material Plant projects will be critical to demonstrating NMG’s operational capabilities and achieving production targets.

Share Price Volatility

The offering’s impact on NMG’s share price will depend on investor perception of the company’s growth prospects and the broader market sentiment towards graphite and battery materials.

Funding Runway

The additional $20 million will extend NMG’s funding runway, but continued access to capital markets at favorable terms will be essential for future expansion plans.

Event summary

• BriaCell's Phase 3 Bria-IMT clinical trial for metastatic breast cancer has been featured in Nature Medicine’s ‘Eleven clinical trials that will shape medicine in 2026’.
• The trial, known as BRIA-ABC, is evaluating BriaCell’s lead candidate, Bria-IMT, in combination with an immune checkpoint inhibitor versus physician’s choice.
• BriaCell anticipates reporting top-line data as early as H1-2026, with interim analysis expected after 144 patient events (deaths).
• Over 160 patients have been enrolled in the Phase 3 trial to date, screened from a pool of over 230.

The big picture

What we're watching

Clinical Efficacy

The interim analysis for overall survival (OS) will be critical; a lack of statistically significant improvement could severely impact BriaCell’s valuation and future development plans.

Regulatory Pathway

The FDA Fast Track designation suggests accelerated review potential, but the trial’s inclusive nature and real-world comparator arm may introduce complexities in the approval process.

Market Adoption

Even with approval, the trial’s focus on patients with extensive prior treatments and diverse subtypes may limit the initial market penetration and require a targeted commercialization strategy.

Event summary

• OSL Group has listed Tether Gold (XAUT), a $2.2 billion gold-backed stablecoin, on its exchanges, offering XAUT/USDT and XAUT/USD trading pairs.
• The partnership with Antalpha aims to build a comprehensive 'Digital Gold' solution for institutional investors in Hong Kong.
• Antalpha has been providing XAUT-to-gold bar redemption services and is now expanding access through OSL's platform.
• The collaboration enables a 'Fiat-Digital Asset-Physical Gold' closed-loop operation within Hong Kong's regulatory framework.

The big picture

What we're watching

Regulatory Scrutiny

Increased regulatory focus on stablecoins and RWA offerings could impact the long-term viability of the partnership and XAUT's adoption in Hong Kong.

Redemption Risk

The ability of XAUT holders to redeem tokens for physical gold bars remains crucial; any disruptions to this process could undermine investor confidence.

Competitive Landscape

The emergence of competing digital gold solutions and stablecoins will likely intensify pressure on OSL and Antalpha to innovate and maintain market share.